세계의 생물학적 탈장 수술 메시 시장 보고서(2025년)
Biologic Hernia Repair Mesh Global Market Report 2025
상품코드 : 1810839
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

생물학적 탈장 수술 메시 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.4%로 24억 6,000만 달러로 성장할 것입니다. 예측 기간 동안의 성장은 탈장 사례의 유병률 증가, 첨단 생물학적 임플란트 채택률 증가, 노인 인구 증가, 최소침습 수술에 대한 선호도 증가, 수술 후 합병증에 대한 인식 증가 등의 요인에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 조직공학 기술의 발전, 차세대 생물학적 비계 개발, 탈세포화 과정의 개선, 생체흡수성 재료 과학의 발전, 생물학적 합성 메시 복합체 생성 등이 있습니다.

탈장 사례의 증가는 생물학적 탈장 수술 메시 시장의 성장을 촉진할 것으로 예상됩니다. 탈장이란 근육이나 결합조직이 약해진 부분을 통해 내장이나 조직이 비정상적으로 돌출되는 것을 말합니다. 탈장 사례의 증가는 주로 비만율의 증가에 기인하며, 과체중은 복부 근육의 압력을 증가시켜 탈장 형성의 위험을 증가시키기 때문입니다. 생물학적 탈장 복원 메시는 치유를 촉진하고 환자의 신체와 통합되어 거부 반응과 만성 염증의 가능성을 최소화하는 천연 조직으로 만들어진 발판을 제공함으로써 이러한 사례의 치료에 사용됩니다. 예를 들어, 2024년 7월 Eurostat의 보고에 따르면 2022년 사타구니 탈장 수술은 인구 10만 명당 142-231회, 오스트리아의 경우 10만 명당 273.2회로 눈에 띄게 높은 수치를 보였습니다. 따라서 탈장 발생률의 증가는 생물학적 탈장 수술 메시 시장의 확대에 기여하고 있습니다.

생물학적 탈장 수술 메시 시장의 주요 기업들은 강도, 유연성 및 조직 통합을 개선하기 위해 강화된 생물학적 메시와 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 강화된 생물학적 메시는 생물학적 조직과 합성섬유를 결합하여 내구성을 높이고 조직 재생을 지원하며 탈장 재발의 위험을 최소화합니다. 예를 들어, 2024년 4월, TELA Bio Inc.는 사타구니 탈장 수리를 위해 설계된 강화된 생물학적 메시인 OviTex 사타구니 탈장 수리(IHR)를 발표했습니다. 복강경 및 로봇 수술에 특화된 이 메시는 생물학적 양 세포 외 기질(ECM)과 최소한의 합성 폴리머의 조합으로 강도를 높이고, 빠른 조직 통합을 지원하며, 합병증 위험을 줄입니다. 낮은 재발률, 빠른 치유, 높은 환자 만족도 등의 장점을 가지고 있어 기존 합성 메시의 한계를 극복하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Biologic hernia repair mesh is an implant made from processed human or animal tissues, used to strengthen and support weakened areas during hernia repair surgeries. The mesh is gradually absorbed by the body, encouraging natural tissue regeneration, which makes it particularly suitable for patients at higher risk of infection or those undergoing complex repairs.

The primary types of biologic hernia repair mesh include partially absorbable and fully absorbable meshes. Partially absorbable meshes are composed of both absorbable and non-absorbable materials. Common variants include porcine, bovine, and human dermis meshes, among others. These meshes are distributed through various channels such as direct sales, distributors, online platforms, and pharmacies. They are used in procedures like inguinal, ventral, and umbilical hernia repairs. Key end users include hospitals, ambulatory surgical centers, clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The biologic hernia repair mesh market research report is one of a series of new reports from The Business Research Company that provides biologic hernia repair mesh market statistics, including the biologic hernia repair mesh industry's global market size, regional shares, competitors with the biologic hernia repair mesh market share, detailed biologic hernia repair mesh market segments, market trends and opportunities, and any further data you may need to thrive in the biologic hernia repair mesh market. This biologic hernia repair mesh market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biologic hernia repair mesh market size has grown strongly in recent years. It will grow from $1.71 billion in 2024 to $1.85 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth during the historic period can be attributed to several factors, including rising healthcare expenditure, increasing clinical evidence supporting efficacy, higher demand for customized and patient-specific implants, greater adoption in veterinary and pediatric surgeries, and the growing burden of obesity and lifestyle-related disorders.

The biologic hernia repair mesh market size is expected to see strong growth in the next few years. It will grow to $2.46 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of hernia cases, higher adoption of advanced biologic implants, a growing geriatric population, rising preference for minimally invasive surgeries, and greater awareness of post-surgical complications. Key trends in the forecast period include advancements in tissue engineering technologies, the development of next-generation biologic scaffolds, improvements in decellularization processes, advancements in bioresorbable material science, and the creation of composite biologic-synthetic meshes.

The increasing prevalence of hernia cases is anticipated to drive the growth of the biologic hernia repair mesh market. Hernias refer to the abnormal protrusion of internal organs or tissues through weakened areas in muscle or connective tissue. The rise in hernia cases is mainly attributed to the growing obesity rates, as excess weight increases pressure on abdominal muscles, raising the risk of hernia formation. Biologic hernia repair mesh is used to treat these cases by providing a scaffold made of natural tissue, which facilitates healing, integrates with the patient's body, and minimizes the chances of rejection or chronic inflammation. For instance, in July 2024, Eurostat reported that inguinal hernia repairs were performed between 142 and 231 times per 100,000 inhabitants in 2022, with Austria having a notably higher rate of 273.2 per 100,000. Therefore, the growing incidence of hernias is contributing to the expansion of the biologic hernia repair mesh market.

Leading companies in the biologic hernia repair mesh market are focusing on the development of innovative solutions, such as reinforced biologic mesh, to improve strength, flexibility, and tissue integration. Reinforced biologic mesh combines biologic tissue with synthetic fibers to enhance durability, support tissue regeneration, and minimize the risk of hernia recurrence. For example, in April 2024, TELA Bio Inc. introduced OviTex inguinal hernia repair (IHR), a reinforced biologic mesh designed for inguinal hernia repair. This mesh is specifically intended for laparoscopic and robotic procedures and uses a combination of biologic ovine extracellular matrix (ECM) and minimal synthetic polymer to deliver strength, support rapid tissue integration, and reduce the risk of complications. It offers advantages such as lower recurrence rates, faster healing, and higher patient satisfaction, addressing the limitations of traditional synthetic meshes.

In February 2024, RTI Surgical Inc., a US-based contract development and manufacturing organization (CDMO), acquired Cook Biotech Inc. for an undisclosed sum. This acquisition allows RTI Surgical to position itself as the only regenerative medicine CDMO capable of providing both allograft and xenograft biomaterials at scale, strengthening its leadership in soft tissue and expanding its market footprint. Cook Biotech Inc. is a US-based company specializing in regenerative medicine, manufactures biologic hernia repair mesh.

Major players in the biologic hernia repair mesh market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company, DSM Biomedical, Baxter International Inc., W. L. Gore & Associates Inc., Meril Life Sciences, Cook Medical LLC, Integra LifeSciences Corporation, MTF Biologics, LifeCell Corporation, AlloSource, TELA Bio Inc., Kerecis, Assut Europe S.p.A., Serag-Wiessner GmbH & Co. KG, Aroa Biosurgery Limited, ACell Inc., Tissue Regenix Group plc., RTI Surgical Inc., Beijing Datsing Bio-Tech Co. Ltd., and Shanghai Pine & Power Biotech Co. Ltd.

North America was the largest region in the biologic hernia repair mesh market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biologic hernia repair mesh report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biologic hernia repair mesh market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biologic hernia repair mesh market consists of sales of Strattice reconstructive tissue matrix, Surgimend, and Ovitex. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biologic Hernia Repair Mesh Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologic hernia repair mesh market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biologic hernia repair mesh ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biologic hernia repair mesh market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Biologic Hernia Repair Mesh Market Characteristics

3. Biologic Hernia Repair Mesh Market Trends And Strategies

4. Biologic Hernia Repair Mesh Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biologic Hernia Repair Mesh Growth Analysis And Strategic Analysis Framework

6. Biologic Hernia Repair Mesh Market Segmentation

7. Biologic Hernia Repair Mesh Market Regional And Country Analysis

8. Asia-Pacific Biologic Hernia Repair Mesh Market

9. China Biologic Hernia Repair Mesh Market

10. India Biologic Hernia Repair Mesh Market

11. Japan Biologic Hernia Repair Mesh Market

12. Australia Biologic Hernia Repair Mesh Market

13. Indonesia Biologic Hernia Repair Mesh Market

14. South Korea Biologic Hernia Repair Mesh Market

15. Western Europe Biologic Hernia Repair Mesh Market

16. UK Biologic Hernia Repair Mesh Market

17. Germany Biologic Hernia Repair Mesh Market

18. France Biologic Hernia Repair Mesh Market

19. Italy Biologic Hernia Repair Mesh Market

20. Spain Biologic Hernia Repair Mesh Market

21. Eastern Europe Biologic Hernia Repair Mesh Market

22. Russia Biologic Hernia Repair Mesh Market

23. North America Biologic Hernia Repair Mesh Market

24. USA Biologic Hernia Repair Mesh Market

25. Canada Biologic Hernia Repair Mesh Market

26. South America Biologic Hernia Repair Mesh Market

27. Brazil Biologic Hernia Repair Mesh Market

28. Middle East Biologic Hernia Repair Mesh Market

29. Africa Biologic Hernia Repair Mesh Market

30. Biologic Hernia Repair Mesh Market Competitive Landscape And Company Profiles

31. Biologic Hernia Repair Mesh Market Other Major And Innovative Companies

32. Global Biologic Hernia Repair Mesh Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biologic Hernia Repair Mesh Market

34. Recent Developments In The Biologic Hernia Repair Mesh Market

35. Biologic Hernia Repair Mesh Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기